Business Standard

MNCs, domestic drug makers did equally well in terms of growth rate

The data shows that in the last 12 months, multinational drugmakers have also done equally well in the Indian market in terms of growth rate

medicine
Premium

Representative Image

Sohini Das Mumbai
Home-grown drug makers enjoy 80 per cent share of the domestic market and take the lion’s share when it comes to brand launches. The data shows that in the last 12 months, multinational drugmakers have also done equally well in the Indian market in terms of growth rate. 

According to the data from market research firm AIOCD AWACS, the moving annual turnover growth for November 2019 (which represents the last 12 months) for Indian firms is 9.9 per cent, while for multinational drug firms, it is at 9.7 per cent. During this period, the overall pharma market grew by 9.8 per

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in